Our data revealed that 149-01 effectively alleviate LPS-induced systemic inflammation, MSU-induced peritonitis and EAE at a dose of 5 mg/kg and its therapeutic effect is dependent on NLRP3. The gene discussed is NLRP3; the disease is peritonitis.